[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-349774-en":3,"detail-sidebar-cat-0-en-105":51,"doc-seo-349774-105":100},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":20,"is_deleted":4,"is_public":21,"is_downloadable":21,"audit_status":21,"page_count":22,"language":23,"language_code":24,"site_id":25,"html_lang":24,"table_of_contents":26,"faqs":27,"seo_title":28,"seo_description":14,"update_tm":29,"read_time":30,"preview_page_count":31,"preview_urls":32},349774,4398048949847,"Eliana","https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267",8,"Research & Report","Recapitulating lung cancer metastasis in vitro - Advances in organoid models and challenges in clinical translation - Review","Lung cancer metastasis drives mortality and remains a major global health challenge. This review consolidates organoid-based approaches that model metastatic progression in vitro, emphasizing physiologically relevant culture systems. It covers key steps for constructing and interrogating organoid metastasis models, including tissue sources, culture modalities, gene editing, and in vivo transplantation. It also highlights applications for studying mechanisms, drug screening, and capturing intra- and intertumoral heterogeneity, while addressing standardization and translational barriers.","ONCOLOGY REPORTS 55: 49, 2026  \nRecapitulating lung cancer metastasis in vitro: Advances in organoid models and challenges in clinical translation (Review)  \nJIAN JIANG 1 , GUOMIN DONG 1 , ZHIYUN ZHANG 1 , XIAOYUAN LEI 1 , FANSHU HUANG 1 , SUONI LI2 , JIEQUN MA2 , JIE BAI2 , QIAN GE3 , HUI WEI4 and ZHENG ZHAO2  \n1Graduate School, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China; 2Department of Internal Medicine, Shaanxi Provincial Cancer Hospital, Xi'an, Shaanxi 710061, P.R. China; 3Graduate School, Xi'an Medical University, Xi'an, Shaanxi 710000, P.R. China; 4Department of Oncology, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi 712046, P.R. China  \nReceived May 28, 2025; Accepted November 26, 2025  \nDOI: 10. 3892/or.2026.9054  \nAbstract. Lung cancer remains a significant global health challenge, with metastatic progression being the leading driver of mortality. Organoid technology provides a tractable, physiologically relevant platform to model key aspects of lung cancer metastasis in vitro. The present review summarized methodologies for constructing and interrogating these models, covering tissue sources, culture modalities, gene editing and in vivo transplantation; applications in studying metastatic mechanisms, drug screening and capturing intra‑ and intertumoral heterogeneity are also highlighted. Persistent challenges include standardizing derivation and culture conditions, improving preservation of tumor‑microenvironmental interactions, expanding immune‑competent and vascularized models, and addressing scalability, cost, and regulatory and ethical considerations for clinical translation . Future directions include integrating multi‑omics approaches and spatial profiling, leveraging artificial intelligence for image and response analytics, advancing immune‑organoid models and establishing shared standards, reference materials and reporting guidelines to enhance reproducibility and clinical impact.  \nCorrespondence to: Professor Hui Wei, Department of Oncology, Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, 2‑A Weiyang West Road, Xianyang, Shaanxi 712046, P.R. China  \nE‑mail: [276077154@qq.com](276077154@qq.com)  \nDr Zheng Zhao, Department of Internal Medicine, Shaanxi Provincial Cancer Hospital, 309 Yanta West Road, Yanta, Xi'an, Shaanxi 710061, P.R. China  \nE‑mail: [zhaozheng710061@163.com](zhaozheng710061@163.com)  \nKey words: lung cancer, organoids, metastasis model, tumor microenvironment, precision medicine, tumor heterogeneity  \nContents  \n1. Introduction  \n2. Definition and stem cell origin of organoids  \n3. Modeling key steps of the metastatic cascade in organoids  \n4. Construction strategies and key technologies for lung cancer organoid metastasis models  \n5. Applications of lung cancer organoid metastasis models in research  \n6. Challenges and future directions in lung cancer organoid metastasis models  \n1. Introduction  \nMetastasis accounts for up to 90% of cancer‑related deaths, driven by complex interplay between malignant cells and the tumor microenvironment (1‑4) . It is a progressive, multistep process in which cancer cells disseminate from the primary tumor, invade surrounding tissue, survive in circulation and colonize distant organs (5,6) . A deeper understanding of how cancer cells deviate from normal programs of growth, motility and stromal‑immune crosstalk is essential for identifying potential targets and optimal time windows for detection, prevention and treatment of the metastatic diseases.  \nLung cancer is the most common and most fatal cancer worldwide, with 2.5 million new cases (12.4% of all global cancers) and 1.8 million deaths (18.7% of global cancer deaths) in 2022 (7); it remains the leading cause of cancer mortality largely due to the high incidence of metastasis (8,9) . Non‑small cell lung cancer (NSCLC) constitutes 80‑85% of all lung cancer cases (10) . While surgical resection bene","cbCaio86cC100rW2","https://ap.wps.com/l/cbCaio86cC100rW2","pdf",1667944,12,1,14,"English","en",105,"# Introduction\n## Definition and stem cell origin of organoids\n## Modeling key steps of the metastatic cascade in organoids\n## Construction strategies and key technologies for lung cancer organoid metastasis models\n## Applications of lung cancer organoid metastasis models in research\n## Challenges and future directions in lung cancer organoid metastasis models","[{\"question\":\"Why is lung cancer metastasis considered a leading cause of cancer death?\",\"answer\":\"Metastatic progression accounts for the majority of cancer-related deaths and reflects a multistep process driven by interactions between malignant cells and the tumor microenvironment.\"},{\"question\":\"What do organoid models contribute to studying lung cancer metastasis in vitro?\",\"answer\":\"Organoid technology offers physiologically relevant platforms to model key aspects of metastasis and to interrogate metastatic mechanisms under controlled conditions.\"},{\"question\":\"What challenges limit clinical translation of organoid metastasis models?\",\"answer\":\"Key challenges include standardizing derivation and culture conditions, preserving tumor microenvironment interactions, expanding immune-competent and vascularized models, and managing scalability, cost, and regulatory or ethical requirements.\"}]","Recapitulating lung cancer metastasis in vitro - Advances in organoid models and challenges in clinical translation - Review | PDF",1790085478,35,4,[33,37,42,47],{"page_no":21,"url":34,"width":35,"height":36},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ba427c14d8a07b2ca72ef384cfa0718.webp",983,1357,{"page_no":38,"url":39,"width":40,"height":41},2,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/020d871372fd76d3567e29e1b721621b.webp",982,1356,{"page_no":43,"url":44,"width":45,"height":46},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcd9299cdfc5aff4be00f687a283acbf.webp",981,1354,{"page_no":31,"url":48,"width":49,"height":50},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7aa972931e4ceb458b33d03b8db9150.webp",980,1353,{"code":4,"msg":5,"data":52},[53,58,62,66,71,76,81,84,89,92,96],{"id":21,"doc_module":4,"doc_module_name":54,"category_name":55,"show_sort_weight":56,"slug":57},"Document","Story & Novel",90,"story-novel",{"id":38,"doc_module":4,"doc_module_name":54,"category_name":59,"show_sort_weight":60,"slug":61},"Literature",80,"literature",{"id":31,"doc_module":4,"doc_module_name":54,"category_name":63,"show_sort_weight":64,"slug":65},"Exam",70,"exam",{"id":67,"doc_module":4,"doc_module_name":54,"category_name":68,"show_sort_weight":69,"slug":70},5,"Comic",60,"comic",{"id":72,"doc_module":4,"doc_module_name":54,"category_name":73,"show_sort_weight":74,"slug":75},6,"Technology",50,"technology",{"id":77,"doc_module":4,"doc_module_name":54,"category_name":78,"show_sort_weight":79,"slug":80},7,"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":54,"category_name":12,"show_sort_weight":82,"slug":83},30,"research-report",{"id":85,"doc_module":4,"doc_module_name":54,"category_name":86,"show_sort_weight":87,"slug":88},9,"Religion & Spirituality",20,"religion-spirituality",{"id":87,"doc_module":4,"doc_module_name":54,"category_name":90,"show_sort_weight":87,"slug":91},"World Cup","world-cup",{"id":93,"doc_module":4,"doc_module_name":54,"category_name":94,"show_sort_weight":93,"slug":95},10,"Lifestyle","lifestyle",{"id":97,"doc_module":4,"doc_module_name":54,"category_name":98,"show_sort_weight":67,"slug":99},19,"General","general",{"code":4,"msg":101,"data":102},"ok",{"site_id":25,"language":24,"slug":103,"title":13,"keywords":104,"description":14,"schema_data":105,"social_meta":158,"head_meta":160,"extra_data":162,"updated_unix":163},"recapitulating-lung-cancer-metastasis-in-vitro-advances-in-organoid-models-and-challenges-in-clinical-translation-review","",{"@graph":106,"@context":157},[107,120,140],{"@type":108,"itemListElement":109},"BreadcrumbList",[110,114,116,118],{"item":111,"name":112,"@type":113,"position":21},"https://docshare.wps.com","Home","ListItem",{"item":115,"name":54,"@type":113,"position":38},"https://docshare.wps.com/document/",{"item":117,"name":12,"@type":113,"position":43},"https://docshare.wps.com/document/research-report/",{"item":119,"name":13,"@type":113,"position":31},"https://docshare.wps.com/document/recapitulating-lung-cancer-metastasis-in-vitro-advances-in-organoid-models-and-challenges-in-clinical-translation-review/349774/",{"url":119,"name":13,"@type":121,"image":122,"author":127,"headline":13,"publisher":129,"fileFormat":132,"inLanguage":24,"description":14,"dateModified":133,"datePublished":134,"encodingFormat":132,"isAccessibleForFree":135,"interactionStatistic":136},"DigitalDocument",{"url":123,"@type":124,"width":125,"height":126},"https://docshare.wps.com/thumbnails/recapitulating-lung-cancer-metastasis-in-vitro-advances-in-organoid-models-and-challenges-in-clinical-translation-review/349774.png","ImageObject",300,407,{"name":9,"@type":128},"Person",{"url":111,"name":130,"@type":131},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":137,"interactionType":138,"userInteractionCount":20},"InteractionCounter",{"@type":139},"ViewAction",{"@type":141,"mainEntity":142},"FAQPage",[143,149,153],{"name":144,"@type":145,"acceptedAnswer":146},"Why is lung cancer metastasis considered a leading cause of cancer death?","Question",{"text":147,"@type":148},"Metastatic progression accounts for the majority of cancer-related deaths and reflects a multistep process driven by interactions between malignant cells and the tumor microenvironment.","Answer",{"name":150,"@type":145,"acceptedAnswer":151},"What do organoid models contribute to studying lung cancer metastasis in vitro?",{"text":152,"@type":148},"Organoid technology offers physiologically relevant platforms to model key aspects of metastasis and to interrogate metastatic mechanisms under controlled conditions.",{"name":154,"@type":145,"acceptedAnswer":155},"What challenges limit clinical translation of organoid metastasis models?",{"text":156,"@type":148},"Key challenges include standardizing derivation and culture conditions, preserving tumor microenvironment interactions, expanding immune-competent and vascularized models, and managing scalability, cost, and regulatory or ethical requirements.","https://schema.org",{"og:url":119,"og:type":159,"og:title":13,"og:site_name":130,"og:description":14},"article",{"robots":161,"canonical":119},"index,follow",{"doc_id":7,"site_id":25},1790316253]